Legal Representation
Attorney
David M. Tener, Esq.
USPTO Deadlines
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 30, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 30, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 30, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 18, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jul 18, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 21, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 18, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| May 22, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jun 28, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 24, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 24, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 24, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 21, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 2, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 2, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 2, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 27, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Nov 21, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 26, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 26, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 6, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 21, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 15, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 14, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 14, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 15, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| May 15, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Feb 14, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 14, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 14, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 7, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 26, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 23, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biochemical preparations for scientific purposes; Chemical and biochemical products in the nature of chemical preparations for scientific use and for research, other than for medical or veterinary use; Chemical and biochemical products in the nature of chemical preparations for scientific use and for research in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-viral particles, other than for medical or veterinary use; Chemical and biochemical test kits for scientific laboratory use and for research use containing chemical preparations, agents and reagents, for life science research, virus, protein, antibody production and in vivo injection; Chemical and biochemical test kits for scientific laboratory use and for research use containing chemical preparations, agents and reagents in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-viral particles; Chemical preparations for scientific purposes; Chemical preparations, agents and reagents for scientific use and for scientific research for genetic diagnosis; Chemical reagents for non-medical purposes
First Use Anywhere:
Apr 1, 2024
First Use in Commerce:
Apr 1, 2024
Class 005
Chemicals and biochemicals for medical and clinical use, namely, chemical and biochemical preparations for discovery and development of cell and gene therapy for treating genetic diseases; Chemicals and biochemicals for medical and clinical use in the field of genetics, namely, chemical and biochemical preparations for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-virus particles for the discovery and development of cell and gene therapies for treating genetic diseases; Diagnostic assay kits and chemical and biochemical diagnostic test kits, all for medical and clinical use in the field of genetics, comprised of preparations, agents and reagents for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-virus particles, for use in disease testing; Pharmaceutical products for the treatment of genetic diseases
First Use Anywhere:
Apr 1, 2024
First Use in Commerce:
Apr 1, 2024
Class 040
Custom manufacture of pharmaceutical products; Treatment of chemical products, namely, chemical synthesis, purification and dispensing; Recycling of chemical products
First Use Anywhere:
Apr 1, 2024
First Use in Commerce:
Apr 1, 2024
Classification
International Classes
001
005
040
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"